Back to Trades
Sell4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$212.6K
Net $126.0K sold
Sales
$126.0K
2 transactions
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Name
- Quart Barry D
- Role
- Insider
- Location
- LONDON, X0
Filing Details
- Filing Date
- Feb 12, 2026
- Transaction Date
- Feb 10, 2026
- Accession Number
- 0001384243-26-000004
- Form Type
- 4
- Net Trading Amount
- -$126.0K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 10, 2026 | Class A Ordinary Share | 110 | $15.47 | Exercise | $1.7K |
| Feb 10, 2026 | Class A Ordinary Share | 110 | $45.00 | Sale | $5.0K |
| Feb 12, 2026 | Class A Ordinary Share | 2,690 | $15.47 | Exercise | $41.6K |
| Feb 12, 2026 | Class A Ordinary Share | 2,690 | $45.00 | Sale | $121.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 10, 2026 | Derivative | 110 | $15.47 | Exercise | $1.7K |
| Feb 12, 2026 | Derivative | 2,690 | $15.47 | Exercise | $41.6K |
Footnotes
- (F1)This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.
- (F2)The option is fully vested and exercisable.